My IDSA Contact Us
IDSA NewsPrint-Friendly Newsletter
Forward to a Friend
Search Back Issues
 
Education & Training Resources Practice Guidelines Journals & Publications Policy & Advocacy Meetings About IDSA
July/August 2012
Top Stories
IDWeek 2012: See you in San Diego!
There’s still time to register for this year’s must-attend event for infectious diseases and other health professionals—IDWeek 2012, Oct. 17-21, in San Diego. Learn more about the first-ever joint meeting of IDSA, HIVMA, SHEA, and PIDS.
H3N2v Information for Clinicians

Following recent developments with influenza virus transmission in the U.S., IDSA recently emailed members a synopsis with links to scientifically sound resources with additional information. 

A Look Back at the AIDS 2012 Conference

The 2012 International AIDS Conference, held in July in Washington, D.C., featured important new science, key policy discussions, and an array of related events hosted by HIVMA and the IDSA/HIVMA Center for Global Health Policy. 

IDSA Journal Club
This month, studies investigating: vaccination for herpes zoster in immunosuppressed older patients; management of severe, left-sided infective endocarditis; safety and efficacy of pandemic influenza A(H1N1) vaccination; and persistence of non-gonococcal urethritis.
Upcoming dates to remember

  • The first-ever combined meeting of IDSA, SHEA, HIVMA, and PIDS, Oct.17-21, 2012, in San Diego. Learn more online by reading the new FAQs section!
  • Register Now!
    Discounted Early Registration Deadline: Friday, Sept. 14, 2012
  • The lineup of keynote speakers, including bios, is online.
  • Plan which sessions to attend by using the Interactive Program Planner.
Patient Care and Science
CDC No Longer Recommends Cefixime as First-Line Treatment for Gonorrhea
Reminder: Registration, Reporting Requirements for Clinical Trials Investigators
Drug Approvals, Recalls, Adverse Events Update
Global ID
U.S. Pledges to Release Blueprint for “AIDS-Free Generation”
Haitian Prison Highlights TB Challenges Despite Improved Diagnostics
Q&A: Global Fund General Manager Gabriel Jaramillo
HIV Treatment as Prevention Among Drug Users
Policy and Advocacy
FDA Takes Steps Towards More Judicious Antimicrobial Use in Animals
IDSA Applauds Finalized Guidelines for HCV Screening
IDSA Comments on Upcoming HHS Antibiotic Incentives Study
Your Colleagues
Check Out “My IDSA” for Latest Member News
Education & Resources
CID Seeks Applicants for Assistant Deputy Editor Position
Updated IDSA Lyme Disease Online Course Offers CME Credit
Top Stories
IDWeek 2012: See you in San Diego!
H3N2v Information for Clinicians
A Look Back at the AIDS 2012 Conference
IDSA Journal Club

IDSA | 1300 Wilson Blvd., Suite 300 | Arlington, VA 22209 | Phone: (703) 299-0200
To ensure delivery, please add 'info@idsociety.org' to your email address book or Safe Sender List.
If you are still having problems receiving our communications,
see our white-listing page for more details.

Unsubscribe here